Building a model and using it to run detailed simulations is one of the best ways to support confident, data-driven decisions in today’s competitive marketplace.
Read More
5 ways a zero-based bioreactor simplifies alternative protein production
Emerging alternative protein manufacturers and the food tech sector have had to rely on biopharma practices, which inhibit scale up with steep price tags and long production times. Here’s how zero-based equipment can help tailor those practices to achieve commercial scale.
Read More
Creating a sustainable heating strategy for pharma manufacturing through decarbonization
Moving past natural gas and electric boilers can achieve the pharmaceutical industry’s decarbonization goals.
Read More
How to set up a team with trade partners and subcontractors for success
Fully integrated teams, that include strategic trade partners rather than subcontractors, exceed client expectations for safety, quality, cost certainty and speed to market.
Read More
Developing a food & beverage production strategy: 5 must-dos for your next capital project
Developing a successful production strategy and plan for your next capital investment project could be the key to scaling up successfully.
Read More
What’s next for the life science industry?
Real talk from the front lines of today’s research and manufacturing landscape
Read More
How adaptive reuse can help life sciences labs make the move to urban centers
The adaptive reuse of existing space for labs is an emerging trend sparked by increased capacity demands, supply chain challenges, and sustainability goals.
Read More
Benefits of membrane filtration systems for ambient WFI production
The shift to membrane-based WFI production can significantly reduce utility use, shrink facility footprint requirements, and help meet corporate sustainability goals.
Read More
The promise of RNA-based therapies
Decades of scientific progress in understanding the root cause of many formerly intractable diseases has opened up new treatment options, namely through RNA-based therapies. This second wave of biopharma, in which our understanding of the ways coding portions of our genome relate to disease, allows us to intercede earlier, and at more specific and effective junctures.
Read More
An introduction to modern monoclonal antibody manufacturing
Monoclonal antibody (mAb) therapies continue to provide both powerful weapons against disease and compelling business opportunities for forward-thinking companies.
Read More